600594.SH · SSE
Guizhou Yibai Pharmaceutical Co.,Ltd.
益佰制药 · 医药卫生 · 贵阳市
Top shareholders · H1 2026
| Rank | Shareholder | Reported shares |
|---|---|---|
| 1 | 窦啟玲 | 185,457,636 |
| 2 | 吕良丰 | 19,129,254 |
| 3 | 郎洪平 | 7,912,009 |
| 4 | 唐计海 | 5,414,500 |
| 5 | 张素芬 | 4,810,000 |
| 6 | 戴文萍 | 4,081,200 |
| 7 | 何忠平 | 3,357,200 |
| 8 | 潘月欣 | 3,088,100 |
| 9 | 何小红 | 2,905,500 |
| 10 | 牟磊 | 2,886,087 |
Top shareholders · Q1 2026
| Rank | Shareholder | Reported shares |
|---|---|---|
| 1 | 窦啟玲 | 185,457,636 |
| 2 | 吕良丰 | 18,606,852 |
| 3 | 张素芬 | 17,230,000 |
| 4 | 郎洪平 | 7,912,009 |
| 5 | Morgan Stanley & Co. International PLC | 5,508,984 |
| 6 | 中国建设银行股份有限公司-诺安多策略混合型证券投资基金 | 4,367,700 |
| 7 | 何忠平 | 3,966,900 |
| 8 | 何小红 | 3,900,600 |
| 9 | 祝龙胜 | 3,761,000 |
| 10 | 唐计海 | 3,714,400 |
Reported top-shareholder data does not establish that a holder bought or sold shares during the period.